Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

Behind the scenes with the unsung heroes of cancer clinical trials – Part 4

We speak to Jane Hair, a biobanker involved in the National Lung Matrix Trial, about what her job involves.

Behind the scenes with the unsung heroes of cancer clinical trials – Part 3

We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.

Behind the scenes with the unsung heroes of cancer clinical trials – Part 2

We speak to Susie Brown, Trial Coordinator on the National Lung Matrix Trial, about what her job involves.

Behind the scenes with the unsung heroes of cancer clinical trials – Part 1

We speak to Cindy Billingham, lead statistician on the National Lung Matrix Trial, about what her job involves.

Vaccine may reduce HPV infections that cause some oral cancers

Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

Pages